Valeo Pharma Inc
TSX:VPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Valeo Pharma Inc
TSX:VPH
|
CA |
|
M
|
Melrose Industries PLC
OTC:MLSPF
|
UK |
|
A
|
Agilent Technologies Inc
XBER:AG8
|
US |
|
Fielmann Group AG
F:FIE1
|
DE |
|
Pan American Silver Corp
TSX:PAAS
|
CA |
|
4
|
4C Group AB
STO:4C
|
SE |
|
Axway Software SA
PAR:AXW
|
FR |
|
AROS Bostadsutveckling AB
F:9HZ
|
SE |
|
Boyuan Holdings Ltd
ASX:BHL
|
AU |
|
Z
|
Zhejiang Huamei Holding Co Ltd
SZSE:000607
|
CN |
|
P
|
Pfizer Inc
XHAM:PFE
|
US |
|
Hermes International SCA
OTC:HESAF
|
FR |
|
ITV PLC
LSE:ITV
|
UK |
|
M
|
Marex Group PLC
NASDAQ:MRX
|
UK |
|
Copenhagen Airports A/S
F:KLH
|
DK |
|
P
|
Park Dental Partners Inc
NASDAQ:PARK
|
US |
|
Elite Pharmaceuticals Inc
OTC:ELTP
|
US |
Bankruptcy Probability
Valeo Pharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Valeo Pharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Valeo Pharma Inc
TSX:VPH
|
4.4m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
538.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
285B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
224.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
208.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Valeo Pharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Valeo Pharma Inc has total debt of 27.8m CAD. This includes both short-term (3.4m CAD) and long-term (24.4m CAD) debt.
You can find a full breakdown on its Balance Sheet.
